M.D. Anderson Cancer Center: Lymphoma, B-Cell, Marginal Zone trials
The registry lists 15 Lymphoma, B-Cell, Marginal Zone studies with M.D. Anderson Cancer Center as lead sponsor. 0 are open to participants now and 5 have results posted.
Early Phase 1 1Phase 1 6Phase 2 9No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) LymphomaCompletedNCT04465162Phase 2Results posted
- Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin LymphomaCompletedNCT01995669Phase 1/2Results posted
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerTerminatedNCT00726830Not applicableResults posted
- Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid MalignanciesCompletedNCT00536978Phase 2Results posted
- Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanCompletedNCT00496873Phase 2Results posted
- ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin LymphomaActive, not recruitingNCT05025800Phase 1/2
- Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT LymphomaActive, not recruitingNCT03680586Early Phase 1
- Vaccine Therapy in Treating Patients With Lymphoplasmacytic LymphomaCompletedNCT01209871Phase 1
- Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
- Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesCompletedNCT01094860Phase 1
- Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell TransplantCompletedNCT00880815Phase 1
- Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWithdrawnNCT00378781Not applicable
- Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaCompletedNCT00003245Phase 2
- Bone Marrow Transplantation in Treating Patients With LymphomaCompletedNCT00002829Phase 2
- Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the StomachCompletedNCT00002682Phase 2